- Home
- EBS vs NKX Comparison
EBS vs NKX Comparison
Compare EBS & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- NKX
- Stock Information
- Founded
- EBS 1998
- NKX 2002
- Country
- EBS United States
- NKX United States
- Employees
- EBS N/A
- NKX N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- NKX Finance/Investors Services
- Sector
- EBS Health Care
- NKX Finance
- Exchange
- EBS Nasdaq
- NKX Nasdaq
- Market Cap
- EBS 529.9M
- NKX 613.8M
- IPO Year
- EBS 2006
- NKX N/A
- Fundamental
- Price
- EBS $10.93
- NKX $12.82
- Analyst Decision
- EBS Strong Buy
- NKX
- Analyst Count
- EBS 1
- NKX 0
- Target Price
- EBS $15.00
- NKX N/A
- AVG Volume (30 Days)
- EBS 1.5M
- NKX 109.3K
- Earning Date
- EBS 10-29-2025
- NKX 01-01-0001
- Dividend Yield
- EBS N/A
- NKX 4.37%
- EPS Growth
- EBS N/A
- NKX N/A
- EPS
- EBS 1.35
- NKX N/A
- Revenue
- EBS $788,900,000.00
- NKX N/A
- Revenue This Year
- EBS N/A
- NKX N/A
- Revenue Next Year
- EBS $15.42
- NKX N/A
- P/E Ratio
- EBS $8.11
- NKX N/A
- Revenue Growth
- EBS N/A
- NKX N/A
- 52 Week Low
- EBS $4.02
- NKX $9.78
- 52 Week High
- EBS $13.41
- NKX $12.00
- Technical
- Relative Strength Index (RSI)
- EBS 57.23
- NKX 53.83
- Support Level
- EBS $9.02
- NKX $12.73
- Resistance Level
- EBS $10.29
- NKX $12.99
- Average True Range (ATR)
- EBS 0.58
- NKX 0.06
- MACD
- EBS -0.03
- NKX -0.03
- Stochastic Oscillator
- EBS 93.69
- NKX 34.62
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.